Clinical Trials Directory

Trials / Completed

CompletedNCT02988635

Early Palliative Care on Quality of Life of Advanced Cancer Patients

Evaluation of Effects of Early Palliative Care on Quality of Life of Advanced Cancer Patients. A Multicenter Controlled Randomised Clinical Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
281 (actual)
Sponsor
Azienda Ospedaliero-Universitaria di Parma · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study compares two types of care - Standard Oncology Care (SOC) and SOC with early palliative care (EPC) (started within 8 weeks after diagnosis of advanced disease) to see which is better for improving the quality of life of patients with advanced lung, pancreas, gastric and biliary tract cancer. The study will use FACT-G questionnaire to measure patients' quality of life.

Detailed description

The patients will complete a baseline FACT-G questionnaire and then will be randomized to a study group. Subjects who are randomized to Standard Oncology Care (SOC) will follow up with their treating oncologist. They will consult with the palliative care team at their request or at the request of the treating oncologist or of the family. They will complete FACT-G questionnaire at 12 weeks after enrollment. Subjects who are randomized to the SOC with Early Palliative Care (EPC) will meet with a palliative care team (basically composed by a palliative care physician and a palliative care specialized nurse) at their next medical oncology or infusion visit. They will meet with the palliative care team at least every three weeks. They will complete FACT-G questionnaire at 12 weeks after enrollment.

Conditions

Interventions

TypeNameDescription
OTHEREarly Palliative CareSubjects who are randomized to the Standard Oncology Care with Early Palliative Care will meet with the palliative care team at their next medical oncology or infusion visit. They will meet with the palliative care clinician at least every three weeks. They will complete questionnaire at 12 weeks after enrollment.

Timeline

Start date
2014-11-01
Primary completion
2016-11-01
Completion
2016-11-01
First posted
2016-12-09
Last updated
2016-12-09

Source: ClinicalTrials.gov record NCT02988635. Inclusion in this directory is not an endorsement.